Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases.

Authors:
Bontemps Y; Scamuffa N; Calvo F; Khatib AM.

Journal:
Med Res Rev

Publication Year: 2007

DOI:
10.1002/med.20072

PMCID:
PMC7168524

PMID:
17019676

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Med Res Rev

Abbreviation: Med Res Rev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Biofabrication approaches and regulatory framework of metastatic tumor-on-a-chip models for precisi…
Nieto D; Jiménez G; Moroni L and 3 more (2022) - Transparency Score: 3/6
Cardiovascular therapeutics: A new potential for anxiety treatment?
Repova K; Aziriova S; Krajcirovicova K and 1 more (2022) - Transparency Score: 2/6
Mutations of TRPM8 channels: Unraveling the molecular basis of activation by cold and ligands.
Plaza-Cayón A; González-Muñiz R; Martín-Martínez M. (2022) - Transparency Score: 3/6
Skin cancer, including related pathways and therapy and the role of luteolin derivatives as potenti…
Juszczak AM; Wöelfle U; Končić MZ and 1 more (2022) - Transparency Score: 3/6
Discovery of K<sub>V</sub> 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenge…
Gubič Š; Hendrickx LA; Toplak Ž and 7 more (2021) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
0/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025